Radiation therapy for cancer spread to a few sites

This trial studies a type of targeted radiation therapy called SABR (stereotactic ablative radiotherapy) for patients whose cancer has spread to only a few sites in the body. Researchers are collecting medical images, blood samples, and health information from patients receiving this treatment across multiple hospitals to use artificial intelligence to figure out which patients will benefit most from it.

While this radiation treatment has shown promise for cancer that has spread to just a few locations, not all patients benefit equally, and doctors need better tools to predict who will have the best outcomes. By studying thousands of patients and analyzing their imaging and blood work with advanced computer learning, researchers hope to personalize treatment decisions and improve survival and quality of life.